Menu
Not yet recruiting NCT06576141

Kaleidoscope Virtual Reality Glasses Pain and Anxiety Levels in Venous Blood Collection Children

No phase Interventional Child, Only

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Kaleidoscope, Virtual Reality, control.
Who it may be relevant to
Registry conditions: Child, Only. Basic parameters: 9 years — 12 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Kaleidoscope and Virtual Reality Glasses on Pain and Anxiety Levels in Venous Blood Collection in Children Aged 9-12

Overview

The aim of our research is to investigate the effects of distracting children's attention with a kaleidoscope and virtual reality glasses during venous blood collection on perceived pain and anxiety levels.

Detailed description

After obtaining the necessary institutional permissions, parents and children who come to the blood collection room will be informed about the research through the "Informed Consent Form". The research data will be collected by the researcher using a face-to-face interview technique. Before the blood collection procedure, the children and their families who will be included in the kaleidoscope group, virtual reality group and control group will be informed about the research. The kaleidoscope will be used 5 minutes before the blood collection procedure as the child who will be included in the kaleidoscope group sits in the patient chair. The nurse will start preparing the child for the blood collection procedure at that time. The nurse will apply a tourniquet and determine the vein from the antecubital region to be taken from. The blood collection procedure will be taken from the antecubital region by the same nurse in one go using a vakuteynir (vacuum blood collection tube) and blood coming to the Vakuteynir within 5 seconds will indicate that the procedure was successful. This procedure will take approximately 2-3 minutes and the children will watch the kaleidoscope throughout the procedure. After the procedure is completed, the children will be taken out of the blood collection room and taken to the waiting area and the children will be asked to determine the level of pain they felt during the procedure. The child will assess how much fear the child experienced during the blood collection procedure and the level of anxiety.

The child who will be taken into the virtual reality group will be seated in the patient chair and virtual reality will be used 5 minutes before the blood collection procedure. The nurse will start preparing the child for the blood collection procedure at that time. The nurse will perform the tourniquet application and the determination of the vein from the antecubital region from which the blood will be taken. The blood collection procedure will be performed by the same nurse in one go from the antecubital region using a vakutainer (vacuum blood collection tube) and blood coming into the vakutainer within 5 seconds will indicate that the procedure was successful. This procedure will take approximately 2-3 minutes and the children will be shown virtual reality throughout the procedure. After the procedure is completed, the children will be taken out of the blood collection room and taken to the waiting area and the children will be asked to determine the level of pain they felt during the procedure. The child will assess how much fear the child experienced during the blood collection procedure and the level of anxiety they experienced. Children in the control group will not undergo any interventional procedures. Blood collection will be arranged to be taken from the antecubital region by the same nurse via a vacutainer. After the procedure is completed, children will be taken out of the blood collection room and taken to the waiting area. After being allowed to rest for 1-2 minutes, a questionnaire will be administered to the children. The child will evaluate how much fear the child has during the blood collection procedure and what their anxiety is. Children in the control group will not undergo any interventional procedures.

Interventions

  • Other Kaleidoscope
    The participation of patients in this group in the study will take approximately 15-20 minutes.
  • Other Virtual Reality
    The participation of patients in this group in the study will take approximately 15-20 minutes.
  • Other control
    The participation of patients in this group in the study will take approximately 5-10 minutes.

Primary outcome measures

  • Wong-Baker Facial Expression Rating Scale (WB-FRS) [Time frame: 1 year]
  • State-Trait Anxiety Inventory for Children [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

The child must be between the ages of 9-12, The child and parents must agree to participate in the research, The child must be able to communicate and be open to communication, The child must not have any hearing, speech or vision disorders

Exclusion criteria

The child is not within the age range specified above The child and parents do not agree to participate in the research. The child has a communication problem The child has a hearing, speech or vision disorder.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Prevention

Study locations

Turkey (Türkiye) · 1 center
  • To Sakarya University Training and Research Hospital — Sakarya

Identifiers

NCT: NCT06576141 · EBYU-SBF-TO-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗